Astellas Establishes Open Innovation Hub for Tumor Microenvironment Research with Cutting-Edge Spatial Biology, in Mitsui Fudosan’s “MITSUI LINK-Lab KASHIWA-NO-HA 1”

Astellas Pharma Inc. and Mitsui Fudosan Co., Ltd. announced that Astellas will establish a “TME imaging and interactive research for innovation ” open innovation hub in October, 2023 in “MITSUI LINK-Lab KASHIWA-NO-HA 1” operated by Mitsui Fudosan.